Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
A significant proportion of HIV infected people in the U.S. are also infected with hepatitis
C virus (HCV). The purpose of this study is to determine the effects of anti-HIV therapy on
treatment of HCV with pegylated interferon alfa-2a and ribavirin (PEG/RBV).
Phase:
N/A
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)